AI-powered Neurodiagnostic Platform for Early Stroke & Alzheimer’s Detection
AI-powered Neurodiagnostic Platform for Early Stroke & Alzheimer’s Detection
Project profile curated by GlobalReach Link. Applications are reviewed on a rolling basis.
Project Overview
A neurohealth-focused venture developing a non-invasive diagnostic tool using AI-powered enzyme analysis to detect risk of stroke and Alzheimer’s disease via saliva and serum. Also functions as an incubator supporting health science innovators to accelerate research translation.
Project Goals
Skills Needed
Competitive Advantage
– Saliva-based at-home solution with AI insight
– Low-cost strips, high diagnostic accuracy
– IP-pending tech with global application
Reasons to Invest & Market Opportunity
– First-mover in non-invasive home neurodiagnostics
– Strong medical partnerships & clinical pipeline
– High-impact, scalable solution for global aging crisis
– $70B+ diagnostics market
– >5500M with dementia; rising global need for early intervention
– Scalable to public health & aged care
Problem & Solution
– Early neurodegenerative diseases lack low-cost diagnostics
– Saliva-based AI strip detects key biomarkers like D-serine
– Non-invasive, portable, cost-efficient
Highlights
– Prototype device completed
– Biomarker validated in multi-region cohorts
– Academic partnerships in AU, MENA & SE Asia
Apply to Join
Applications are reviewed by the GlobalReach coordination team. Only shortlisted experts will be contacted (NDA for documents).
Sign in may be required before submission.